Imaging Mass Cytometry™ of malignant tissue architecture: rare single cells to structured multi-cellular communities

Dr Andrew Quong, Chief Science Officer, Fluidigm

Before joining Fluidigm, Dr Quong was an Associate Professor at Georgetown University and then Thomas Jefferson University. He then moved to the Frederick National Laboratory for Cancer Research, where he was Director of Strategic Initiatives and Partnerships. Dr Quong took systems biology approaches to understanding the underlying molecular mechanisms of progression and the interaction of cells within the tumour microenvironment. He joined Fluidigm in May 2019 as Chief Scientific Officer and has led the development of the Fluidigm® Therapeutic Insights Services team, which offers expert consultation and tailored sample-to-answer research projects.

Dr Hartland Jackson, Investigator, Lunenfeld-Tanenbaum Research Institute

Dr Jackson is an Investigator at the Lunenfeld-Tanenbaum Research Institute. He is a leader in Imaging Mass Cytometry™ and is one of the most experienced users of the Hyperion™ Imaging System worldwide. He was part of the development of the histoCAT™ computational toolbox for interactively investigating highly multiplex IMC data and has applied these methods to quantify the cellular architecture of breast cancer in large clinical cohorts. He is now extending this approach to other cancers and complementary mouse model systems in order to identify and target multi-cellular mechanisms of cancer progression and therapeutic resistance.